In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs

被引:14
|
作者
Onishi, Hiraku [1 ]
Machida, Yoshiharu [1 ]
机构
[1] Hoshi Univ, Dept Drug Delivery Res, Shinagawa Ku, Tokyo 1428501, Japan
关键词
macromolecular prodrug; microparticles; nanoparticles; controlled release; in vivo behavior;
D O I
10.3390/molecules13092136
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macromolecular prodrugs are very useful systems for achieving controlled drug release and drug targeting. In particular, various macromolecule-antitumor drug conjugates enhance the effectiveness and improve the toxic side effects. Also, polymeric micro- and nanoparticles have been actively examined and their in vivo behaviors elucidated, and it has been realized that their particle characteristics are very useful to control drug behavior. Recently, researches based on the combination of the concepts of macromolecular prodrugs and micro- or nanoparticles have been reported, although they are limited. Macromolecular prodrugs enable drugs to be released at a certain controlled release rate based on the features of the macromolecule-drug linkage. Micro- and nanoparticles can control in vivo behavior based on their size, surface charge and surface structure. These merits are expected for systems produced by the combination of each concept. In this review, several micro- or nanoparticles composed of macromolecule-drug conjugates are described for their preparation, in vitro properties and/or in vivo behavior.
引用
收藏
页码:2136 / 2155
页数:20
相关论文
共 50 条
  • [1] In vitro evaluation of dendrimer prodrugs for oral drug delivery
    Najlah, Mohammad
    Freeman, Sally
    Attwood, David
    D'Emanuele, Antony
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 336 (01) : 183 - 190
  • [2] Drug delivery to brain by microparticulate systems
    Kas, HS
    BIOMATERIALS: FROM MOLECULES TO ENGINEERED TISSUES, 2004, 553 : 221 - 230
  • [3] Synthesis and in vitro evaluation of macromolecular prodrugs of norfioxacin
    Coessens, V.
    Schacht, E.
    Journal of Controlled Release, 48 (2-3):
  • [4] TESTING OF IN-VITRO DISSOLUTION BEHAVIOR OF MICROPARTICULATE DRUG-DELIVERY SYSTEMS
    CONTI, B
    GENTA, I
    GIUNCHEDI, P
    MODENA, T
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (10) : 1223 - 1233
  • [5] Polyester dendritic systems for drug delivery applications:: In vitro and in vivo evaluation
    De Jesús, OLP
    Ihre, HR
    Gagne, L
    Fréchet, JMJ
    Szoka, FC
    BIOCONJUGATE CHEMISTRY, 2002, 13 (03) : 453 - 461
  • [6] Microparticulate systems for targeted drug delivery to phagocytes
    Jhunjhunwala, Siddharth
    Little, Steven R.
    CELL CYCLE, 2011, 10 (13) : 2047 - 2048
  • [7] In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits
    Lim, ST
    Forbes, B
    Berry, DJ
    Martin, GP
    Brown, MB
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 231 (01) : 73 - 82
  • [8] In Vitro Evaluation of Amphiphilic Macromolecular Nanocarriers for Systemic Drug Delivery
    Harmon, Alexander M.
    Uhrich, Kathryn E.
    JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2009, 24 (02) : 185 - 197
  • [9] Nasal delivery of human growth hormone:: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system
    Leitner, VM
    Guggi, D
    Krauland, AH
    Bernkop-Schnürch, A
    JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) : 87 - 95
  • [10] MACROMOLECULAR DRUG CARRIER SYSTEMS IN CANCER-CHEMOTHERAPY - MACROMOLECULAR PRODRUGS
    TAKAKURA, Y
    HASHIDA, M
    CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1995, 18 (03) : 207 - 231